Citation: K. Last et al., A PHASE-I DOSE-ESCALATION OF HYDROXYUREA (HU) IN ADDITION TO CONTINUOUS-INFUSION 5-FLUOROURACIL (5FU) IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, European journal of cancer, 34, 1998, pp. 71-71
Citation: Kw. Last et al., LONG-TERM INTRAVENOUS ACCESS DEVICES - SUPERIORITY OF PERIPHERALLY INSERTED CENTRAL CANNULAE (PICCS) OVER HICKMAN CATHETERS (HCS), Annals of oncology, 9, 1998, pp. 681-681
Authors:
GOGAS H
LOFTS FJ
EVANS TRJ
DARYANANI S
MANSI JL
Citation: H. Gogas et al., ARE SERIAL MEASUREMENTS OF CA19-9 USEFUL IN PREDICTING RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH INOPERABLE ADENOCARCINOMA OF THE PANCREAS, British Journal of Cancer, 77(2), 1998, pp. 325-328
Authors:
FOX SB
LEEK RD
BLISS J
MANSI JL
GUSTERSON B
GATTER KC
HARRIS AL
Citation: Sb. Fox et al., ASSOCIATION OF TUMOR ANGIOGENESIS WITH BONE-MARROW MICROMETASTASES INBREAST-CANCER PATIENTS, Journal of the National Cancer Institute, 89(14), 1997, pp. 1044-1049
Authors:
EVANS TRJ
MANSI JL
MORGAN DAL
GYI KM
BANHAM SW
MILROY R
Citation: Trj. Evans et al., A PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Oncology Reports, 4(6), 1997, pp. 1337-1341
Citation: J. Diffley et Jl. Mansi, INTRATUMORAL COLLAGEN CHEMOTHERAPY - NOVEL THERAPEUTIC STRATEGY FOR ACCESSIBLE TUMORS/, European journal of cancer, 33, 1997, pp. 1456-1456
Citation: Fj. Lofts et al., BILE-DUCT STENTS - IS THERE AN INCREASED RATE OF COMPLICATIONS IN PATIENTS RECEIVING CHEMOTHERAPY, European journal of cancer, 33(2), 1997, pp. 209-213
Authors:
GOGAS H
LOFTS FJ
EVANS TRJ
MILLARD FJC
WILSON R
MANSI JL
Citation: H. Gogas et al., OUTPATIENT TREATMENT WITH EPIRUBICIN AND ORAL ETOPOSIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER, British Journal of Cancer, 76(5), 1997, pp. 639-642
Citation: Cl. Harper et al., PROSTATE-SPECIFIC ANTIGEN (PSA) IMMUNOHISTOCHEMISTRY IN THE PRESENCE OF A NORMAL SERUM PSA AS AN AID TO DIAGNOSIS OF ADENOCARCINOMA OF UNKNOWN PRIMARY SITE, British Journal of Hospital Medicine, 55(6), 1996, pp. 367-368
Citation: Trj. Evans et al., A PHASE-II STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL WITH CISPLATINAND EPIRUBICIN IN INOPERABLE PANCREATIC-CANCER, British Journal of Cancer, 73(10), 1996, pp. 1260-1264
Citation: Cm. Oakley et Jl. Mansi, THE IMPLEMENTATION OF A HOME CHEMOTHERAPY SERVICE - A COLLABORATIVE PROJECT BETWEEN HOSPITAL END COMMUNITY, European journal of cancer, 31A, 1995, pp. 1324-1324
Citation: Trj. Evans et al., A RANDOMIZED STUDY TO DETERMINE WHETHER ROUTINE INTRAVENOUS MAGNESIUMSUPPLEMENTS ARE NECESSARY IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY WITH CONTINUOUS-INFUSION 5-FLUOROURACIL, European journal of cancer, 31A(2), 1995, pp. 174-178
Authors:
KEDAR RP
COSGROVE DO
SMITH IE
MANSI JL
BAMBER JC
Citation: Rp. Kedar et al., BREAST-CARCINOMA - MEASUREMENT OF TUMOR RESPONSE TO PRIMARY MEDICAL THERAPY WITH COLOR DOPPLER FLOW IMAGING, Radiology, 190(3), 1994, pp. 825-830
Authors:
EVANS TRJ
MANSI JL
BULL R
FALLOWFIELD ME
BEVAN DH
PATH MRC
HARMER CL
DALGLEISH AG
Citation: Trj. Evans et al., EOSINOPHILIC FOLLICULITIS OCCURRING AFTER BONE-MARROW AUTOGRAFT IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Cancer, 73(10), 1994, pp. 2512-2514
Authors:
SEYMOUR MT
MANSI JL
GALLAGHER CJ
GORE ME
HARPER PG
EVANS TRJ
EDMONDS PM
SLEVIN ML
Citation: Mt. Seymour et al., PROTRACTED ORAL ETOPOSIDE IN EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY IN PATIENTS WITH RELAPSED OR PLATINUM-RESISTANT DISEASE, British Journal of Cancer, 69(1), 1994, pp. 191-195
Authors:
CUNNINGHAM D
HILL ME
MILAN S
MANSI JL
SMITH IE
CATOVSKY D
GORE M
OBRIEN MER
NICOLSON M
HICKISH T
Citation: D. Cunningham et al., VEEP CHEMOTHERAPY FOR ADULT HODGKINS-DISEASE - ASSESSMENT OF EFFICACYAND GONADAL AND CARDIAC TOXICITY, Blood, 84(10), 1994, pp. 10000162-10000162